chrisvoncsefalvay/vaers-outcomes huggingface dataset:
He was feeling fine in the morning and he went to work, and at work he started feeling nausea and chills, and he started throwing up at work. He came back home and took alka seltzer for his stomach. He felt better and didn't throw up anymore after that.
Client reported heart palpitations approximately 30 minutes after vaccination. These symptoms resolved about 30 minutes after they started.
This spontaneous report was received from a pharmacist concerning a patient of unknown age and gender. The patient's pertinent medical history or concurrent conditions were not provided. Around on 09-NOV-2015, the patient was vaccinated with a dose of PNEUMOVAX 23, lot # K016294, expiration date: 28-APR-2016, (dose, anatomical location and route were not reported). Co-suspect therapies or concomitant medications were not provided. On an unknown date in November 2015, the patient experienced cellulitis at the injection site after receiving of PNEUMOVAX 23. The pharmacist reported that patient could not work for 3 days due to cellulitis. The outcome of injection site cellulitis was unknown. The relatedness between the event and suspect therapy was not provided. No product quality complaint was involved. Additional information has been requested.
This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (two or three days were sick like they had the flu, after the first dose) in a 52-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043B21A) for COVID-19 vaccination. Patient was not having allergies to medications, food and other products. No any medical history relating to mentioned AE and both Acute and Chronic illnesses at the time of vaccination was reported. No other vaccines given within 1 month prior to Moderna COVID-19 vaccine. The patient's past medical history included COVID-19 on 03-Feb-2020. On 02-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INFLUENZA LIKE ILLNESS (two or three days were sick like they had the flu, after the first dose). At the time of the report, INFLUENZA LIKE ILLNESS (two or three days were sick like they had the flu, after the first dose) outcome was unknown. mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged. No concomitant medications was reported. It was reported that events did not cause patient to seek medical care. It was reported patient had not experienced similar events in past. No treatment information was reported. This case was linked to MOD-2022-561915 (Patient Link).
I started to have problems after my first dose. But since the fourth dose I had a second bone marrow because my blood tones keep dropping. My liver blocked off my bile duct and currently in the hospital now.
Tested Covid-19 positive after vaccination; Tested Covid-19 positive after vaccination; sneezing; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 77-year-old female patient received BNT162b2 (BNT162B2), on 17Feb2021 as dose 1, single (Lot number: EL9264), on 09Mar2021 as dose 2, single (Lot number: EN6207) and in 2021 as dose 3, booster (single) (Lot number: FF8841) at the age of 76 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "brain surgery" (unspecified if ongoing), notes: many years ago when she had her brain surgery; "Asthma Has had it all her life" (unspecified if ongoing), notes: Asthma Has had it all her life. There were no concomitant medications. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "Tested Covid-19 positive after vaccination"; SNEEZING (non-serious), outcome "unknown". The patient underwent the following laboratory tests and procedures: Blood test: unknown results, notes: She is under the care of a neurologist who does blood test periodically to make sure the levels of the medication are correct; SARS-CoV-2 test: Positive. Therapeutic measures were taken as a result of vaccination failure, covid-19, sneezing.  Clinical course: Gave primary care physician the message this morning that she was stopping the medication. Caller was an asthmatic and has been all her life. She developed a horrid cough from the COVID. Almost like she was choking. She was choking from coughing. It was not fun. It was a deep cough. It was awful. It was hard to catch her breath. The patient was treated with paxlovid for the events on 31May2022 or 01June2022. She was reading the material from Pfizer last night, then went to bed. She had been taking the Paxlovid for 2.5 days. Her temples started squeezing and it was reminiscent of many years ago when she had the brain surgery. Vaccination facility type was pharmacy. No history of all previous immunization with the Pfizer vaccine considered as suspect. No additional vaccines were administered on same date of the Pfizer suspect. The adverse events did not require a visit to emergency room nor physician office. No prior vaccinations (within 4 weeks) prior to the first administration date of the suspect vaccine(s). Always get the flu shot in Oct. She has had the pneumonia and shingles vaccines and others. She has bene having vaccines and shots since she was 10 years old for allergies. There were no predisposing factors.
This spontaneous report as received from a medical assistant refers to multiple unspecified patients of unknown age and gender, who on an unspecified dates were administered the improperly stored VARIVAX (merck) (doses and routes not reported) lot # reported as 1629AA, exp: 18-OCT-2013. The reporter stated that a satellite office had experienced an ongoing temperature excursion from December of 2012 through September of 2013. During this temperature excursions VARIVAX (merck) was not supported and was affected. This is one of several reports received from the same source. Additional information has been requested.
Vomiting - extreme exhaustion - red welt on arm which traveled down to my elbow.  the area that had the weld is now discolored and looks like bruising but it's been over 2 weeks
I was having a lot of muscle spasms and stiff neck and neck pain. It was like a stress reaction. I have really low blood pressure and the fatigue was so strong I started to pass out just standing. I was having numbness in my eyes and hands and my eyes were twitching. My feet and hands and ankles were swelling. I was really just not feeling well. So they did an ANA screen and I high ANA screen, so I had to go to a rheumatologist for an auto immune disorder. I have lost 30 pounds so far since this began.
No reactions immediately after vaccine was given. Resident has dementia, has had multiple hospitalizations related to a renal stone recently. Had a tooth that was bothering her, went to see her dentist and it was extracted on 1/6/21. On 1/10 they noted feet and ankles are dark purple with white splotches appears to be mottling. Minimally responsive to voice and touch. Not eating. Compassionate visit with family. Family did not want hospice, did not feel it was needed, said, what more could they do for her than you're already doing?  On 1/11 at 1950 was determined to be deceased.
Received An Expired Dose of Heplisav-B; Initial Report Received on 23-Sep-2022  This is a spontaneous report, received from a pharmacist regarding a 32-year-old- female, who received HEPLISAV-B for hepatitis B immunisation.   There was no medical history reported for the patient.  Concomitant medications were not reported.  On 23-Sep-2022, a dose of HEPLISAV B (Lot #934976, expiration date 30-JUL-2022, NDC #43528-003-05, S/N 520194073663), route not specified, was administered intramuscularly in the left deltoid for hepatitis B immunisation.   On 23-Sep-2022, the patient received an expired dose of HEPLISAV-B. The pharmacist was not certain if the injection was the patient's 1st or 2nd dose of the series. To the pharmacist's knowledge, the patient did not experience any adverse side effects, and the patient was going to be notified regarding the receipt of an expired dose.  No further information was available at the time of the report.   Company Comment: The company assessed the event as non-serious.; Sender's Comments: The company assessed the event as non-serious.
Had pain in the arm near the site and the neck and the shoulder; Had pain in the arm near the site and the neck and the shoulder; Soreness in her right arm the day of the vaccination which went away; This is a spontaneous report from a contactable consumer or other non-health care professional (patient) from a Pfizer sponsored program. A 46-years-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot number: FA7485), via an unspecified route of administration (at the age of 46-years), administered in arm right on 20Aug2021 at 16:15 as dose 1, single for COVID-19 immunization. Medical history included hypertension from 2010 to an unknown date. Concomitant medications included caffeine, paracetamol (EXCEDRIN), paracetamol (TYLENOL) taken for an unspecified indication, start and stop date were not reported. On 20Aug2021, the patient experienced soreness in her right arm the day of the vaccination which went away. On 27Aug2021, experienced had pain in the arm near the site and the neck and the shoulder. It was further stated that caller received her first dose of the vaccine on 20Aug2021. Caller said she experienced soreness in her right arm the day of the vaccination which went away. On 27Aug2021, the soreness came back in her right arm, right side of her neck, and right shoulder. Caller asked if this was related to the vaccine. Soreness in the arm, shoulder, and neck all on the right side was reported as worsened. The caller was questioning the side effects of the Pfizer Covid 19 vaccine. On 20Aug2021 the caller got the first dose and she has soreness through her arm where she received the vaccine and in her neck and her shoulder. The caller clarified and confirmed that the first day the caller had soreness in her arm only and took some Advil and it was fine. The pain came back Friday. The caller then had pain in the arm near the site and the neck and the shoulder. The caller does not know if this is shot related or just a coincidence. The soreness in the arm only was immediately after she received the vaccine and it lasted about a half of day. And then this Friday, 27Aug2021, the caller had soreness in the arm, shoulder, and neck all on the right side. The treatment was received for all the adverse events. The adverse event did not resulted in emergency room and physician office visit. The vaccine was not administered at military facility. The clinical outcome for the event Soreness in her right arm the day of the vaccination which went away was reported as unknown while for event had pain in the arm near the site and the neck and the shoulder was reported as not recovered.
Drank milk, stuffy nose a/leaving home; 9AM vomited x 1;
About 1/2 hour after receiving vaccine, pt complained of abdominal pain, when mom was getting Tylenol, he became pale and lost consciousness for 2-3 minutes. Was drowsy. Lethargic 20 minutes. Flaccid, hyporesponsive.
This case was reported by a consumer via call center representative and described the occurrence of headache in a 61-year-old male patient who received SHINGRIX for prophylaxis. Previously administered products included SHINGRIX (1st dose received on an unknown date and experienced no adverse events). On 29th January 2019, the patient received the 2nd dose of SHINGRIX. In January 2019, less than a week after receiving SHINGRIX, the patient experienced headache, chills, upset stomach, fatigue, general body pain, injection site pain and influenza like illness. On an unknown date, the outcome of the headache, chills, upset stomach, fatigue, general body pain, injection site pain and influenza like illness were not recovered/not resolved. It was unknown if the reporter considered the headache, chills, upset stomach, fatigue, general body pain, injection site pain and influenza like illness to be related to SHINGRIX. Additional details were reported as follows: The patient stated that he did not experience any adverse effects from the 1st SHINGRIX vaccination. However with the 2nd SHINGRIX vaccination he was currently experiencing symptoms (not resolved). The patient said they were bearable and that he almost feels like he had the flu. The patient experienced headache, chills, upset stomach, fatigue and soreness. The patient had pain at injection site but he also felt achy all over.
pt recvd vax 7SEP93 & approx 10 days p/vax pt devel a fine generalized red rash, nausea, vomiting, fatigue, genl malaise & fever; No further details were provided;
Presented to EC on 03/20 for "... presented for PEG tube being dislodged.  He has history of severe malnutrition, recurrent aspirations prompting PEG placement ... On presentation he had HR in 120's and was started on cardizem gtt.  He was found positive for COVID.  He did have 2 doses of the COVID vaccine - second dose avout 2-3 weeks prior to admission.:    Tests, all NAA / PCR: 07/25/2020 SARS-CoV-2 (COVID-19) NOT detected 09/01/2020 SARS-CoV-2 (COVID-19) NOT detected 12/31/2020 SARS-CoV-2 (COVID-19) detected 03/18/2021 SARS-CoV-2 (COVID-19) detected
Approximately 2 minutes after patient received vaccination, she reported dizziness and feeling like her skin was on fire.  She also reported some tingling of her tongue and throat.  She was administered Benadryl PO x 1 dose and monitored for approximately 60 minutes.  Her symptoms improved and she left in improved condition.
Itchy, raised rashes beginning on 25NOV21.  Rashes would appear where skin was scratched and disappear after about half an hour, unless skin was further irritated by scratching.  Had a teleheath appointment on 30NOV21, diagnosis was "Urticaria, unspecified."  Tried Benadryl, Claritin, and hydrocortisone cream for at home care, all of which helped.  Visited urgent care on 09DEC21, report noted that "rashes are consistent with dermatographia."  Would have gone to primary care rather than urgent care, but primary care provider did not have available appointments and suggested visiting urgent care to avoid a long wait.
Vaccine was administered too soon, first dose was administered on 7/16/21 and second dose was administered 13 days later on 7/29/21. VAR was completed and signed off by technician but pharmacist had not performed data entry and DUR on vaccination before administered.
Knee pain; Head pain; This is a spontaneous report from a non-contactable consumer, the patient. A 70-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration in the left arm on 02Feb2021 (at the age of 70-years-old) as a single dose for COVID-19 immunisation. The patient also received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL9266), via an unspecified route of administration in the left arm on 23Feb2021 at 10:15 (at the age of 70-years-old) as a single dose for COVID-19 immunisation. Medical history included unspecified allergies. Concomitant medication included levothyroxine (LEVOTHYROXINE) taken from an unknown date for an unknown indication.  Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On an unspecified date in 2021, the patient experienced knee pain and head pain. The events did not result in a doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. care. The clinical outcome of the events knee pain and head pain was unknown at the time of this report.   No follow-up attempts are possible; information about lot number cannot be obtained.
had bouts of tinnitus after his Moderna Covid-19 vaccines, developed tinnitus over the past several months; painful left arm injection site.; This spontaneous case was reported by a consumer and describes the occurrence of TINNITUS (had bouts of tinnitus after his Moderna Covid-19 vaccines, developed tinnitus over the past several months) and VACCINATION SITE PAIN (painful left arm injection site.) in a 63-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 005C21A and 040B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 16-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 15-May-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced VACCINATION SITE PAIN (painful left arm injection site.). On an unknown date, the patient experienced TINNITUS (had bouts of tinnitus after his Moderna Covid-19 vaccines, developed tinnitus over the past several months). At the time of the report, TINNITUS (had bouts of tinnitus after his Moderna Covid-19 vaccines, developed tinnitus over the past several months) and VACCINATION SITE PAIN (painful left arm injection site.) outcome was unknown.            No concomitant medications were reported. No treatment details were reported. It was reported that the patient had developed Tinnitus over last several months.   This case was linked to MOD-2022-569010, MOD-2022-569013 (Patient Link).
Patient received Flu shot on October 20 and became ill the same day. He was vomiting and shivering. He died the day after receiving Flu shot.
ACUTE DVT OF RIGHT CALF, UNSPECIFIED VEIN ACUTE HYPOXEMIC RESPIRATORY FAILURE ACUTE PULMONARY EMBOLISM CARDIOGENIC SHOCK SHOCK, UNSPECIFIED
Starting approx 4 days after getting the flu shot, the tip of my left thumb starting to feel numb. The next day or 2 later, the numbing sensation spread further down my thumb. Then, it spread to the distal part of my left 2nd digit. Now, about 12 days later, I have had sporadic tingling go up the inside of my legs, starting at my ankle and spread up to my inner thigh, bilaterally. Numbing sensation on both left fingers is a constant feeling and has yet to go away.
Patient fainted.  Awoke and was shaking , fingers and hands rigid and claw-like in a spasm.  Rigidity lasted about 20 minutes.  Advised patient to lie on floor, took deep breaths. Moved to chair after about 20 minutes.  Drank gatorade. rested in chair until fingers relaxed.  Walked about store. Left at about 40 minutes after fainting.
Allergic urticaria, wheezing, cough variant asthma, cough, elevated white blood cells. Hives are constant, all day long on every part of my body, when flared up my chest gets tight and I have a hard time breathing.
Pt developed a 8cm X 4cm red, warm indurated and swollen area on left upper arm, 48 hours, post vax of DTAP.
Fever, vomiting, headache, arm sore/stiffness, muscle aches
Suspected vaccination failure; shingles; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were provided as follows: The patient had reported for him/herself. The age at vaccination was not reported. After receiving Shingles vaccine, the patient got shingles. The patient stated that, it was not preventable. This case was considered as suspected vaccination failure, since the details regarding the completion of the primary immunization, time to onset for event and laboratory confirmation of shingles were not provided.
Vaccination site erythema; Swoleness in the vaccination area; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (Vaccination site erythema) and VACCINATION SITE SWELLING (Swoleness in the vaccination area) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003D21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 23-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 ml. On 24-Mar-2021, the patient experienced VACCINATION SITE ERYTHEMA (Vaccination site erythema) and VACCINATION SITE SWELLING (Swoleness in the vaccination area). At the time of the report, VACCINATION SITE ERYTHEMA (Vaccination site erythema) and VACCINATION SITE SWELLING (Swoleness in the vaccination area) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications was given. No laboratory details was given. No treatment information was given
I have been a Type 1 diabetic for 52 years. After receiving the injection on Friday I was fine, the next day Saturday (7pm)  my blood glucose dropped significantly.   For approx 3 hours my glucose meter register low, while I consumed at least 95 grams of carbohydrates.  Normally 20 grams of carbs would be sufficient.
sore arm-no big deal; violent chills; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team, Program ID. The reporter is the patient.  An 81-year-old female patient received bnt162b2, bnt162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose 3 (booster), single (Batch/Lot number: unknown) intramuscular, in arm for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose 1, single), for Covid-19 immunization, reaction(s): "violent chills", "sore arm-no big deal"; Bnt162b2 (Dose 2, single), for Covid-19 immunization, reaction(s): "violent chills", "sore arm-no big deal". The following information was reported: PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "sore arm-no big deal"; CHILLS (non-serious), outcome "recovered", described as "violent chills". Additional information: She's had 5 previous Covid vaccines, and all of them have been from Pfizer. With the five previous vaccinations, she felt all of them go into her arm muscle. She has managed to get the vaccines and boosters, and managed to never get Covid and she doesn't want to start now. Usually she feels it go into her muscle and she gets a bit of a sore arm-no big deal. Then about twelve hours later on the money every time, she has gotten violent chills that last about another 12 hours or so.   The information on the batch/lot number for bnt162b2, bnt162b2 omi ba.4-5 has been requested and will be submitted if and when received.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300322023 Same reporter/patient/event, different dose;
Don't feel good at all; Feel like chills and the temperature; Feel like chills and the temperature; Not feeling myself today; This is a spontaneous report from a contactable consumer (patient).  A patient of unspecified age and gender received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 28Dec2020 at single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. In Dec2020 after vaccination, patient didn't feel good at all, the patient just feel like chills and the temperature and the patient was not feeling myself. The outcome of the events was unknown.   Information on lot number/Batch number was requested.
Flu vaccine approximately 8:45am today. Approximtely 1 hour later, dizzy, blurry vision, unable to walk in steady straight line. No LOC, no N/V.